Revolutionizing Glaucoma Care with Convenience and Innovation
At SightMD, we are proud to offer dropless glaucoma treatments—a breakthrough approach that relieves patients of the burden of daily eye drop regimens. This innovative treatment option is designed for those living with glaucoma, aiming to control intraocular pressure (IOP) with less dependence on topical medications. Our goal is to make managing glaucoma simpler, more effective, and more consistent, so you can stay focused on your life—not your eye drops.
What Is Dropless Glaucoma Treatment?
Dropless glaucoma treatment refers to long-lasting therapies that reduce or eliminate the need for daily prescription eye drops. These include:
- Sustained-Release Implants (e.g., iDose, Durysta): Tiny implants inserted directly into the eye that slowly release medication over time to help lower IOP.
- Minimally Invasive Glaucoma Surgeries (MIGS): Procedures that improve the eye’s natural drainage system and may significantly reduce or eliminate the need for drops.
- Laser Treatments (e.g., Selective Laser Trabeculoplasty – SLT): A quick, in-office procedure that lowers IOP and may work as a first-line treatment or reduce reliance on drops.
Benefits of Dropless Glaucoma Therapy
- Improved adherence: No more worrying about missing drops or following complicated schedules.
- Better IOP control: Sustained delivery of medication can provide more consistent pressure regulation.
- Reduced side effects: Fewer preservatives and less surface irritation than daily drops.
- Greater freedom: Travel, work, and daily life are easier without managing eye drops.
Is Dropless Glaucoma Treatment Right for You?
If you’re living with glaucoma and find it difficult to stay consistent with your medications, or you experience irritation or allergic reactions from drops, dropless therapy might be a great option. Our team of glaucoma specialists at SightMD will evaluate your condition, lifestyle, and treatment goals to recommend the best solution for you.
Meet Our Glaucoma Specialists
SightMD’s board-certified ophthalmologists are leaders in advanced glaucoma care. Many of our providers are among the first in their region to offer cutting-edge treatments like iDose and SLT. With locations across New York, New Jersey, Connecticut, and Pennsylvania, expert care is always close to home.
Dropless Glaucoma Treatment FAQs
A: The iDose is a tiny, FDA-approved device inserted into the eye during a brief, minimally invasive procedure. It delivers a steady amount of glaucoma medication over several months or even years, reducing or eliminating the need for daily drops.
A: Most patients report little to no discomfort. The procedure is typically done in an outpatient setting with local anesthesia and minimal recovery time.
A: Duration depends on the treatment. iDose may last for years, Durysta (a biodegradable implant) typically lasts several months, while laser therapy results can last 1–5 years. Your ophthalmologist will tailor the treatment plan to your needs.
A: In some cases, yes. Some patients may still need a drop or two, but significantly fewer than before. Others may be able to stop using drops altogether.
A: As with any procedure, there are potential risks, such as inflammation or infection. However, serious complications are rare, and our surgeons take every precaution to ensure a safe and successful outcome.
A: Many dropless glaucoma therapies, including certain implants and laser treatments, are covered by Medicare and most insurance plans. Our team will help you verify your coverage and understand any out-of-pocket costs.
A: Schedule a consultation with one of our glaucoma specialists. We’ll evaluate your eye health, review your current treatment plan, and discuss whether dropless options are right for you.
Take the First Step Toward Dropless Vision Care
If you’re ready to simplify your glaucoma treatment and explore dropless options, SightMD is here to help. Let our team of compassionate, experienced specialists design a treatment plan tailored just for you.